225 related articles for article (PubMed ID: 25661084)
1. CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection.
Yoshida O; Dou L; Kimura S; Yokota S; Isse K; Robson SC; Geller DA; Thomson AW
Transpl Immunol; 2015 Mar; 32(2):76-83. PubMed ID: 25661084
[TBL] [Abstract][Full Text] [Related]
2. CD39 expression by hepatic myeloid dendritic cells attenuates inflammation in liver transplant ischemia-reperfusion injury in mice.
Yoshida O; Kimura S; Jackson EK; Robson SC; Geller DA; Murase N; Thomson AW
Hepatology; 2013 Dec; 58(6):2163-75. PubMed ID: 23813862
[TBL] [Abstract][Full Text] [Related]
3. Blockade of the 4-1BB (CD137)/4-1BBL and/or CD28/CD80/CD86 costimulatory pathways promotes corneal allograft survival in mice.
Asai T; Choi BK; Kwon PM; Kim WY; Kim JD; Vinay DS; Gebhardt BM; Kwon BS
Immunology; 2007 Jul; 121(3):349-58. PubMed ID: 17376197
[TBL] [Abstract][Full Text] [Related]
4. Liver grafts from CD39-overexpressing rodents are protected from ischemia reperfusion injury due to reduced numbers of resident CD4+ T cells.
Pommey S; Lu B; McRae J; Stagg J; Hill P; Salvaris E; Robson SC; d'Apice AJ; Cowan PJ; Dwyer KM
Hepatology; 2013 Apr; 57(4):1597-606. PubMed ID: 22829222
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells in transplantation: does extracellular adenosine triphosphate metabolism through CD39 play a crucial role?
Salcido-Ochoa F; Tsang J; Tam P; Falk K; Rotzschke O
Transplant Rev (Orlando); 2010 Apr; 24(2):52-66. PubMed ID: 20153159
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells play a critical role in mediating inflammation and graft failure during antibody-mediated rejection of kidney allografts.
Kohei N; Tanaka T; Tanabe K; Masumori N; Dvorina N; Valujskikh A; Baldwin WM; Fairchild RL
Kidney Int; 2016 Jun; 89(6):1293-306. PubMed ID: 27165816
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel biomarker gene set with sensitivity and specificity for distinguishing between allograft rejection and tolerance.
Xie L; Ichimaru N; Morita M; Chen J; Zhu P; Wang J; Urbanellis P; Shalev I; Nagao S; Sugioka A; Zhong L; Nonomura N; Takahara S; Levy GA; Li XK
Liver Transpl; 2012 Apr; 18(4):444-54. PubMed ID: 22162188
[TBL] [Abstract][Full Text] [Related]
8. Modulation of nucleoside [correction of nucleotide] triphosphate diphosphohydrolase-1 (NTPDase-1)cd39 in xenograft rejection.
Imai M; Takigami K; Guckelberger O; Enjyoji K; Smith RN; Lin Y; Csizmadia E; Sévigny J; Rosenberg RD; Bach FH; Robson SC
Mol Med; 1999 Nov; 5(11):743-52. PubMed ID: 10656876
[TBL] [Abstract][Full Text] [Related]
9. CD39 limits P2X7 receptor inflammatory signaling and attenuates sepsis-induced liver injury.
Savio LEB; de Andrade Mello P; Figliuolo VR; de Avelar Almeida TF; Santana PT; Oliveira SDS; Silva CLM; Feldbrügge L; Csizmadia E; Minshall RD; Longhi MS; Wu Y; Robson SC; Coutinho-Silva R
J Hepatol; 2017 Oct; 67(4):716-726. PubMed ID: 28554875
[TBL] [Abstract][Full Text] [Related]
10. Graft tumor necrosis factor receptor-1 protects after mouse liver transplantation whereas host tumor necrosis factor receptor-1 promotes injury.
Conzelmann LO; Lehnert M; Kremer M; Zhong Z; Wheeler MD; Lemasters JJ
Transplantation; 2006 Nov; 82(9):1214-20. PubMed ID: 17102774
[TBL] [Abstract][Full Text] [Related]
11. Beneficial effects of CD39/ecto-nucleoside triphosphate diphosphohydrolase-1 in murine intestinal ischemia-reperfusion injury.
Guckelberger O; Sun XF; Sévigny J; Imai M; Kaczmarek E; Enjyoji K; Kruskal JB; Robson SC
Thromb Haemost; 2004 Mar; 91(3):576-86. PubMed ID: 14983235
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for tolerance: high-level expression of donor major histocompatibility complex in the liver overcomes naive and memory alloresponses to skin grafts.
Cunningham EC; Tay SS; Wang C; Rtshiladze M; Wang ZZ; McGuffog C; Cubitt J; McCaughan GW; Alexander IE; Bertolino P; Sharland AF; Bowen DG; Bishop GA
Transplantation; 2013 Jan; 95(1):70-7. PubMed ID: 23263501
[TBL] [Abstract][Full Text] [Related]
13. IRF-1 promotes liver transplant ischemia/reperfusion injury via hepatocyte IL-15/IL-15Rα production.
Yokota S; Yoshida O; Dou L; Spadaro AV; Isse K; Ross MA; Stolz DB; Kimura S; Du Q; Demetris AJ; Thomson AW; Geller DA
J Immunol; 2015 Jun; 194(12):6045-56. PubMed ID: 25964490
[TBL] [Abstract][Full Text] [Related]
14. CD25+CD4+ regulatory T cells develop in mice not only during spontaneous acceptance of liver allografts but also after acute allograft rejection.
Steger U; Kingsley CI; Karim M; Bushell AR; Wood KJ
Transplantation; 2006 Nov; 82(9):1202-9. PubMed ID: 17102772
[TBL] [Abstract][Full Text] [Related]
15. Unique gene expression profiles of heart allograft rejection in the interferon regulatory factor-1-deficient mouse.
Erickson L; Crews G; Pan F; Fisniku O; Jang MS; Wynn C; Kobayashi M; Jiang H
Transpl Immunol; 2004 Nov; 13(3):169-75. PubMed ID: 15381199
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
17. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH
J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971
[TBL] [Abstract][Full Text] [Related]
18. Prolonged renal allograft survival by donor interleukin-6 deficiency: association with decreased alloantibodies and increased intragraft T regulatory cells.
Wang H; Guan Q; Lan Z; Li S; Ge W; Chen H; Nguan CY; Du C
Am J Physiol Renal Physiol; 2012 Jan; 302(2):F276-83. PubMed ID: 22031852
[TBL] [Abstract][Full Text] [Related]
19. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
20. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade.
Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L
Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
